• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化精神分裂症抗精神病药物反应的早期预测

Optimizing early prediction for antipsychotic response in schizophrenia.

作者信息

Chang Yue-Cune, Lane Hsien-Yuan, Yang Kung-Han, Huang Chieh-Liang

机构信息

Institute of Life Science and Department of Mathematics, Tamkang University, Tamsui, Taipei, Taiwan.

出版信息

J Clin Psychopharmacol. 2006 Dec;26(6):554-9. doi: 10.1097/01.jcp.0000246211.95905.8c.

DOI:10.1097/01.jcp.0000246211.95905.8c
PMID:17110810
Abstract

OBJECTIVE

Researchers, by studying first-generation antipsychotics, have established an early prediction model, which had a favorable specificity but a low sensitivity. This study aims to optimize early prediction of treatment response for schizophrenia using a novel statistic method that can be done even under the Microsoft Excel system of a personal computer.

METHODS

One hundred twenty-three inpatients with acutely exacerbated schizophrenia were given optimal therapy of risperidone, a commonly used second-generation antipsychotic agent. Response was defined as a reduction of 20% or more in the Positive and Negative Syndrome Scale total score. We applied the generalized estimating equation method's logistic regression to establish an early prediction model based on the treatment results of the first and the second weeks.

RESULTS

The proposed method correctly predicted nonresponse at 4 and 6 weeks in 80.8% and 81.8% of the patients, respectively. The method also identified responder at 4 and 6 weeks in 80.0% and 82.8%, respectively. The predictive powers (or correct prediction rates) at 4 and 6 weeks were 80.3% and 82.4%, respectively. In addition, the results based on the responses in Positive and Negative Syndrome Scale scores were slightly better than those in Brief Psychiatric Rating Scale scores.

CONCLUSIONS

Using the first 2 weeks' treatment results to predict the fourth or sixth week's treatment response is acceptable in terms of specificity, sensitivity, and predictive power. Further studies are needed. Moreover, whether this model could be applied to establish a prediction system for other psychotropics, such as antidepressants, also deserves research.

摘要

目的

研究人员通过对第一代抗精神病药物的研究,建立了一个早期预测模型,该模型具有良好的特异性,但敏感性较低。本研究旨在使用一种即使在个人计算机的Microsoft Excel系统下也能完成的新型统计方法,优化精神分裂症治疗反应的早期预测。

方法

123例急性加重期精神分裂症住院患者接受了常用的第二代抗精神病药物利培酮的优化治疗。反应定义为阳性和阴性症状量表总分降低20%或更多。我们应用广义估计方程法的逻辑回归,根据第一周和第二周的治疗结果建立早期预测模型。

结果

所提出的方法分别在4周和6周时正确预测无反应的患者比例为80.8%和81.8%。该方法在4周和6周时分别识别出有反应者的比例为80.0%和82.8%。4周和6周时的预测能力(或正确预测率)分别为80.3%和82.4%。此外,基于阳性和阴性症状量表评分反应的结果略优于简明精神病评定量表评分的结果。

结论

就特异性、敏感性和预测能力而言,利用前两周的治疗结果预测第四周或第六周的治疗反应是可以接受的。需要进一步研究。此外,该模型是否可应用于建立其他精神药物(如抗抑郁药)的预测系统也值得研究。

相似文献

1
Optimizing early prediction for antipsychotic response in schizophrenia.优化精神分裂症抗精神病药物反应的早期预测
J Clin Psychopharmacol. 2006 Dec;26(6):554-9. doi: 10.1097/01.jcp.0000246211.95905.8c.
2
Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
J Clin Psychopharmacol. 2009 Aug;29(4):391. doi: 10.1097/JCP.0b013e3181ad3226.
3
Risperidone-related weight gain: genetic and nongenetic predictors.利培酮相关体重增加:遗传和非遗传预测因素。
J Clin Psychopharmacol. 2006 Apr;26(2):128-34. doi: 10.1097/01.jcp.0000203196.65710.2b.
4
RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.RGS4基因多态性可预测精神分裂症患者的临床表现及对利培酮治疗的反应。
J Clin Psychopharmacol. 2008 Feb;28(1):64-8. doi: 10.1097/jcp.0b013e3181603f5a.
5
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.早期精神病的口服与注射用抗精神病药物治疗:两项研究的事后比较
Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.
6
Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.佩罗哌隆与利培酮治疗精神分裂症患者的随机临床对照研究:关西精神科多中心研究
Psychiatry Clin Neurosci. 2009 Jun;63(3):322-8. doi: 10.1111/j.1440-1819.2009.01947.x.
7
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.抗抑郁药引发的早期改善能否预测疗效/缓解情况?对大量重度抑郁症住院患者的自然主义研究数据进行分析。
J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.
8
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.一项在慢性精神分裂症患者中,将丙戊茶碱添加到利培酮治疗的安慰剂对照研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):726-32. doi: 10.1016/j.pnpbp.2007.11.021. Epub 2007 Nov 23.
9
Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.精神分裂症的缓解:对精神分裂症或分裂情感性障碍患者使用利培酮长效注射剂(RLAI)的意大利为期一年的前瞻性研究。
Hum Psychopharmacol. 2009 Oct;24(7):574-83. doi: 10.1002/hup.1067.
10
Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.一组土耳其难治性精神分裂症患者中氯氮平治疗反应的临床预测因素
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1330-6. doi: 10.1016/j.pnpbp.2007.06.002. Epub 2007 Jun 12.

引用本文的文献

1
Association of serum brain-derived neurotrophic factor level and early response to antipsychotic drug in first-episode patients with schizophrenia.首发精神分裂症患者血清脑源性神经营养因子水平与抗精神病药物早期反应的相关性
Int J Methods Psychiatr Res. 2023 Jul 23;33(1):e1982. doi: 10.1002/mpr.1982.
2
Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.早期无应答可预测精神分裂症患者对抗精神病药物的后期无应答:一项随机试验。
BMC Med. 2023 Jul 19;21(1):263. doi: 10.1186/s12916-023-02968-7.
3
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial.
在一项大规模随机对照试验中,第 2 周的抗精神病药物早期疗效可预测第 6 周的后续反应。
Curr Neuropharmacol. 2023;21(2):424-436. doi: 10.2174/1570159X21666221118164612.
4
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".日本神经精神药理学学会:《精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2021 Sep;41(3):266-324. doi: 10.1002/npr2.12193. Epub 2021 Aug 12.
5
Proposing and Validating the Diagnosis Scale for Internet Gaming Disorder in Taiwanese ADHD Adolescents: Likert Scale Method Based on the DSM-5.台湾注意力缺陷多动障碍青少年网络游戏障碍诊断量表的提出与验证:基于《精神疾病诊断与统计手册》第5版的李克特量表法
Int J Environ Res Public Health. 2021 Feb 4;18(4):1492. doi: 10.3390/ijerph18041492.
6
Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications.精神分裂症药物临床试验中终点定义与随机临床试验持续时间的关联。
JAMA Psychiatry. 2020 Oct 1;77(10):1064-1071. doi: 10.1001/jamapsychiatry.2020.1596.
7
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics.早期预测指标:精神分裂症患者使用非典型抗精神病药物治疗的疗效不佳。
BMC Psychiatry. 2018 Dec 4;18(1):376. doi: 10.1186/s12888-018-1950-1.
8
Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.在接受奥氮平治疗的青少年精神分裂症患者中,第2周和第3周的早期反应或无反应可预测最终反应或无反应:一项为期6周的随机、安慰剂对照试验的结果
Eur Child Adolesc Psychiatry. 2015 Dec;24(12):1485-96. doi: 10.1007/s00787-015-0725-1. Epub 2015 Jun 2.
9
Clozapine: a review of clinical practice guidelines and prescribing trends.氯氮平:临床实践指南和处方趋势综述。
BMC Psychiatry. 2014 Apr 7;14:102. doi: 10.1186/1471-244X-14-102.
10
Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER).接受帕利哌酮长效片(帕利哌酮 ER)治疗的精神分裂症患者早期应答的影响因素和预测因子。
Psychiatry Investig. 2013 Dec;10(4):407-16. doi: 10.4306/pi.2013.10.4.407. Epub 2013 Dec 16.